| Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: Protocol for an open-label, parallel-group, superiority … JSH Wong, M Nikoo, JN Westenberg, JG Suen, JYC Wong, RM Krausz, ... Addiction Science & Clinical Practice 16 (11), 1-10, 2021 | 40 | 2021 |
| Shifting North American drug markets and challenges for the system of care RM Krausz, JN Westenberg, N Mathew, G Budd, JSH Wong, VWL Tsang, ... International Journal of Mental Health Systems 15, 1-8, 2021 | 34 | 2021 |
| Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials E Moazen-Zadeh, K Ziafat, K Yazdani, MM Kamel, JSH Wong, ... The American journal of drug and alcohol abuse 47 (3), 280-304, 2021 | 32 | 2021 |
| A Case Report: Rapid Micro‐Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended‐Release in an Adolescent With Severe Opioid Use Disorder P Azar*, JSH Wong*, S Jassemi, E Moore, DX Vo, M Nikoo, S Young The American Journal on Addictions 29 (6), 531-535, 2020 | 29 | 2020 |
| Understanding eHealth Cognitive Behavioral Therapy Targeting Substance Use: Realist Review F Shams, JSH Wong, M Nikoo, A Outadi, E Moazen-Zadeh, MM Kamel, ... Journal of Medical Internet Research 23 (1), e20557, 2021 | 21 | 2021 |
| Non-beverage alcohol consumption among individuals experiencing chronic homelessness in Edmonton, Canada: a cross-sectional study JN Westenberg, MM Kamel, S Addorisio, M Abusamak, JSH Wong, ... Harm reduction journal 18, 1-11, 2021 | 13 | 2021 |
| An inside look at BC's illicit drug market during the COVID-19 pandemic N Mathew, JSH Wong, RM Krausz British Columbia Medical Journal 63 (1), 9-13, 19, 2021 | 12 | 2021 |
| Been there, done that: lessons from Vancouver’s efforts to stem the tide of overdose deaths MR Krausz, JSH Wong, E Moazen-Zadeh, KL Jang The Canadian Journal of Psychiatry 65 (6), 377-380, 2020 | 11 | 2020 |
| Treatment approaches and outcome trajectories for youth with high‐risk opioid use: A narrative review JN Westenberg, AMY Tai, J Elsner, MM Kamel, JSH Wong, P Azar, DX Vo, ... Early Intervention in Psychiatry 16 (3), 207-220, 2022 | 9 | 2022 |
| Canada’s response to the dual public health crises: a cautionary tale RM Krausz, JSH Wong, JN Westenberg, F Choi, CG Schütz, KL Jang The Canadian Journal of Psychiatry 66 (4), 349-353, 2021 | 9 | 2021 |
| Developing a rapid transfer from opioid full agonist to buprenorphine:“Ultrarapid micro-dosing” proof of concept P Azar, N Mathew, D Mahal, JSH Wong, JN Westenberg, CG Schütz, ... Journal of Psychoactive Drugs 55 (1), 94-101, 2023 | 7 | 2023 |
| Systematic review on intentional non-medical fentanyl use among people who use drugs VWL Tsang, JSH Wong, JN Westenberg, NH Ramadhan, H Fadakar, ... Frontiers in Psychiatry 15, 1347678, 2024 | 6 | 2024 |
| Case report: acute care management of severe opioid withdrawal with IV fentanyl P Azar, JN Westenberg, MJ Ignaszewski, JSH Wong, G Isac, N Mathew, ... Addiction Science & Clinical Practice 17 (1), 22, 2022 | 6 | 2022 |
| The effects of opium tincture and methadone on the cognitive function of patients with opioid use disorder JSH Wong, M Nikoo, K Kianpoor, A Gholami, M Jazani, F Mohammadian, ... Personality and Individual Differences 169, 110091, 2020 | 5 | 2020 |
| 48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method P Azar, JSH Wong, N Mathew, M Vogel, J Perrone, AA Herring, ... Journal of Addiction Medicine, 10.1097, 2022 | 4 | 2022 |
| Caenorhabditis elegans Learning and Memory JSH Wong, CH Rankin Oxford Research Encyclopedia of Neuroscience, 2019 | 4 | 2019 |
| Cost Analysis of Buprenorphine Extended-Release Injection Versus Sublingual Buprenorphine/Naloxone Tablets in a Correctional Setting JSH Wong, S Masson, A Huang, D Romm, M Fong, T Porter, N Sharifi, ... Journal of Correctional Health Care 28 (6), 368-371, 2022 | 3 | 2022 |
| Opium tincture versus methadone for opioid agonist treatment: A randomized controlled trial M Nikoo, K Kianpoor, N Nikoo, S Javidanbardan, A Kazemi, F Choi, ... Addiction, 2022 | 3 | 2022 |
| 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine P Azar, JSH Wong, N Mathew, MJ Ignaszewski, N Partovi, RM Krausz, ... Journal of Addiction Medicine 18 (1), 82-85, 2024 | 1 | 2024 |
| Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder P Azar, H Schneiderman, H Barron, JSH Wong, M Meyer, ... Addiction Science & Clinical Practice 19 (1), 50, 2024 | | 2024 |
Reinhard Michael KrauszProfessor of Psychiatry, University of British Columbia在 ubc.ca 的电子邮件经过验证
